AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Respiree secures additional funding in a Series A extension led by We Venture Capital and ClavystBio to enhance its global commercial efforts.
One Six 8 VenturesSeeds CapitalGreenwillow Capital ManagementAdaptive Capital PartnersBizedge CapitalArkray & Partners Pte. Ltd.Clavyst BioWe Venture Capital
Description
Respiree, a health tech company, has expanded its Series A funding round to support growth. The round is led by We Venture Capital and ClavystBio, with participation from several other investors. The funds will be used to grow its commercial team and expand in the U.S. market
Company Information
Company
Respiree
Location
Houston, Texas, United States
About
Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated artificial intelligence (AI) for managing disease progression across healthcare’s care continuum. The 1Bio™ platform by Respiree™ uses data from the EHR and its proprietary US-patented and FDA-cleared sensors to longitudinal measure and track disease progression. Respiree™ is now available in U.S., Australia and Asia-Pacific (APAC). Respiree™ is CE marked, has received regulatory clearances in Australia from the Therapeutics Goods Administration and has received the 510k clearance from the United States Food and Drug Administration (FDA).
Fundz sees it the moment Respiree raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HoustonInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMachine Learning